RLFTY (MindMaze Therapeutics Holding) FCF Yield %: -21.19 (As of Jul. 02, 2026)


RLFTY MindMaze Therapeutics Holding SA RLFTY
11 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding FCF Yield %?

MindMaze Therapeutics Holding RLFTY 11 FCF Yield % is -21.19 as of Jul. 02, 2026. GuruFocus rates RLFTY with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 1,414 Biotechnology companies, MindMaze Therapeutics Holding ranks worse than 69.52% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, MindMaze Therapeutics Holding's Trailing 12-Month Free Cash Flow is $-9.07 Mil, and Market Cap is $66.59 Mil. Therefore, MindMaze Therapeutics Holding's FCF Yield % for today is -21.19%.

The historical rank and industry rank for MindMaze Therapeutics Holding's FCF Yield % or its related term are showing as below:

RLFTY' s FCF Yield % Range Over the Past 10 Years
Min: -21.19   Med: 0   Max: 0
Current: -21.19

RLFTY's FCF Yield % is ranked worse than
69.52% of 1414 companies
in the Biotechnology industry
Industry Median: -9.46 vs RLFTY: -21.19

MindMaze Therapeutics Holding's FCF Margin % for the quarter that ended in Dec. 2025 was -1,125.68%.

MindMaze Therapeutics Holding FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

MindMaze Therapeutics Holding FCF Yield % Related Terms

MindMaze Therapeutics Holding FCF Yield % Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding FCF Yield % Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
FCF Yield %
0.00 -2.11

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
FCF Yield % 0.00 -2.11

RLFTY vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, MindMaze Therapeutics Holding's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindMaze Therapeutics Holding FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's FCF Yield % distribution charts can be found below:

* The bar in red indicates where MindMaze Therapeutics Holding's FCF Yield % falls into.


RLFTY
11GF Score
MindMaze Therapeutics Holding SA RLFTY
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

MindMaze Therapeutics Holding's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-9.073 / 430.33764
=-2.11%

MindMaze Therapeutics Holding's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-9.073 * 1 / 430.33764
=-2.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -21.19 mean?
MindMaze Therapeutics Holding (RLFTY) has a FCF Yield % of -21.19 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MindMaze Therapeutics Holding and its competitors. According to the industry distribution chart, MindMaze Therapeutics Holding ranks #983 out of 1414 companies in the Biotechnology industry, placing it in the top 69.5%.
Is MindMaze Therapeutics Holding's FCF Yield % too high?
MindMaze Therapeutics Holding's current FCF Yield % is -21.19. Based on the distribution chart, MindMaze Therapeutics Holding ranks #983 out of 1414 companies in the Biotechnology industry, which is below the industry midpoint. Overall, MindMaze Therapeutics Holding has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MindMaze Therapeutics Holding ranks #983 out of 1414 companies for FCF Yield %. This places MindMaze Therapeutics Holding in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on MindMaze Therapeutics Holding and its competitors. MindMaze Therapeutics Holding's current FCF Yield % is -21.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (RLFTY) has a current FCF Yield % of -21.19. The current FCF Yield % is -21.19. MindMaze Therapeutics Holding's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For MindMaze Therapeutics Holding (RLFTY), the current FCF Yield % is -21.19 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges MMTXz:UKMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
11GF Score

Get the complete analysis for RLFTY

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price